benzinga.comInsider Decision: Gary Charles Robb Offloads $225K Worth Of Corcept Therapeutics Stock2 days ago
benzinga.comMajor Update: LEONARD BAKER JR At Corcept Therapeutics Exercises Options, Realizing $08 days ago
businesswire.comCorcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call4 months ago
businesswire.comCorcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism6 months ago
businesswire.comCorcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes6 months ago
businesswire.comCorcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes6 months ago
businesswire.comCorcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call8 months ago
finance.yahoo.comCorcept Therapeutics Incorporated's (NASDAQ:CORT) Stock Is Going Strong: Is the Market Following Fundamentals?9 months ago
finance.yahoo.comCorcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast9 months ago
CashuCorcept Therapeutics: Insider Sale Raises Questions About Leadership Confidence and Future Growth2 days ago
CashuCorcept Therapeutics: Executive Sell Signals Insights into Leadership Confidence and Market Perception4 days ago
CashuCorcept Therapeutics Board Member Exercising Stock Options Reflects Confidence in Company’s Future6 days ago